Source:http://linkedlifedata.com/resource/pubmed/id/20960307
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2010-10-20
|
pubmed:abstractText |
Herpes simplex virus type 1 (HSV-1) is a commonly occurring human pathogen worldwide. There is an urgent need to discover and develop new alternative agents for the management of HSV-1 infection. Tripterygium hypoglaucum (level) Hutch (Celastraceae) is a traditional Chinese medicine plant with many pharmacological activities such as anti-inflammation, anti-tumor and antifertility. The usual medicinal part is the roots which contain about a 1% yield of alkaloids. A crude total alkaloids extract was prepared from the roots of T. hypoglaucum amd its antiviral activity against HSV-1 in Vero cells was evaluated by cytopathic effect (CPE) assay, plaque reduction assay and by RT-PCR analysis. The alkaloids extract presented low cytotoxicity (CC(50) = 46.6 ?g/mL) and potent CPE inhibition activity, the 50% inhibitory concentration (IC(50)) was 6.5 ?g/mL, noticeably lower than that of Acyclovir (15.4 ?g /mL). Plaque formation was significantly reduced by the alkaloids extract at concentrations of 6.25 ?g/mL to 12.5 ?g/mL, the plaque reduction ratio reached 55% to 75 which was 35% higher than that of Acyclovir at the same concentration. RT-PCR analysis showed that, the transcription of two important delayed early genes UL30 and UL39, and a late gene US6 of HSV-1 genome all were suppressed by the alkaloids extract, the expression inhibiting efficacy compared to the control was 74.6% (UL30), 70.9% (UL39) and 62.6% (US6) respectively at the working concentration of 12.5 ?g/mL. The above results suggest a potent anti-HSV-1 activity of the alkaloids extract in vitro.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1995-820X
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
25
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
107-14
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:20960307-Alkaloids,
pubmed-meshheading:20960307-Animals,
pubmed-meshheading:20960307-Antiviral Agents,
pubmed-meshheading:20960307-Cercopithecus aethiops,
pubmed-meshheading:20960307-Cytopathogenic Effect, Viral,
pubmed-meshheading:20960307-Gene Expression,
pubmed-meshheading:20960307-Herpesvirus 1, Human,
pubmed-meshheading:20960307-Inhibitory Concentration 50,
pubmed-meshheading:20960307-Microbial Viability,
pubmed-meshheading:20960307-Plant Extracts,
pubmed-meshheading:20960307-Plant Roots,
pubmed-meshheading:20960307-Transcription, Genetic,
pubmed-meshheading:20960307-Tripterygium,
pubmed-meshheading:20960307-Viral Plaque Assay,
pubmed-meshheading:20960307-Viral Proteins
|
pubmed:year |
2010
|
pubmed:articleTitle |
In vitro anti-viral activity of the total alkaloids from Tripterygium hypoglaucum against herpes simplex virus type 1.
|
pubmed:affiliation |
Biomedicine Research and Development Center of Jinan University, Guangzhou 510632, China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|